Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Persister cancer cells: Iron addiction and vulnerability to ferroptosis
Raphaël Rodriguez, Stuart L. Schreiber, Marcus Conrad
Molecular Cell (2021) Vol. 82, Iss. 4, pp. 728-740
Open Access | Times Cited: 172

Showing 1-25 of 172 citing articles:

A non-canonical vitamin K cycle is a potent ferroptosis suppressor
Eikan Mishima, Junya Ito, Zijun Wu, et al.
Nature (2022) Vol. 608, Iss. 7924, pp. 778-783
Open Access | Times Cited: 428
Phase separation of FSP1 promotes ferroptosis
Toshitaka Nakamura, Clara Hipp, André Mourão, et al.
Nature (2023) Vol. 619, Iss. 7969, pp. 371-377
Open Access | Times Cited: 174
A druggable copper-signalling pathway that drives inflammation
Stéphanie Solier, Sebastian Müller, Tatiana Cañeque, et al.
Nature (2023) Vol. 617, Iss. 7960, pp. 386-394
Open Access | Times Cited: 150
Astaxanthin attenuates osteoarthritis progression via inhibiting ferroptosis and regulating mitochondrial function in chondrocytes
Xuezhong Wang, Haohuan Li, Puji Peng, et al.
Chemico-Biological Interactions (2022) Vol. 366, pp. 110148-110148
Closed Access | Times Cited: 77
Long noncoding RNA LINC01606 protects colon cancer cells from ferroptotic cell death and promotes stemness by SCD1–Wnt/β‐catenin–TFE3 feedback loop signalling
Yajun Luo, Siqi Huang, Jinlai Wei, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 4
Open Access | Times Cited: 74
Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy
Amir Ajoolabady, Daolin Tang, Guido Kroemer, et al.
British Journal of Cancer (2022) Vol. 128, Iss. 2, pp. 190-205
Open Access | Times Cited: 73
Ferroptosis: mechanisms and implications for cancer development and therapy response
Ancély Ferreira dos Santos, Gholamreza Fazeli, Thamara Nishida Xavier da Silva, et al.
Trends in Cell Biology (2023) Vol. 33, Iss. 12, pp. 1062-1076
Closed Access | Times Cited: 71
Ferroptosis in health and disease
Carsten Berndt, Hamed Alborzinia, Vera Skafar Amen, et al.
Redox Biology (2024) Vol. 75, pp. 103211-103211
Open Access | Times Cited: 69
Drug-tolerant persister cells in cancer: the cutting edges and future directions
Yi Pu, Lu Li, Haoning Peng, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 11, pp. 799-813
Closed Access | Times Cited: 62
Cardamonin alleviates chondrocytes inflammation and cartilage degradation of osteoarthritis by inhibiting ferroptosis via p53 pathway
Ziheng Gong, Yanjie Wang, Lan Li, et al.
Food and Chemical Toxicology (2023) Vol. 174, pp. 113644-113644
Closed Access | Times Cited: 55
An integrated view of lipid metabolism in ferroptosis revisited via lipidomic analysis
Jong Woo Kim, Ji-Yoon Lee, Mihee Oh, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 8, pp. 1620-1631
Open Access | Times Cited: 54
Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis
Joseph M. Hendricks, Cody E. Doubravsky, Eddie Wehri, et al.
Cell chemical biology (2023) Vol. 30, Iss. 9, pp. 1090-1103.e7
Open Access | Times Cited: 52
Lipids as mediators of cancer progression and metastasis
Felix C. E. Vogel, Adriano B. Chaves‐Filho, Almut Schulze
Nature Cancer (2024) Vol. 5, Iss. 1, pp. 16-29
Closed Access | Times Cited: 48
Regulation of antioxidants in cancer
Fábio Hecht, Marco Zocchi, Fatemeh Alimohammadi, et al.
Molecular Cell (2023) Vol. 84, Iss. 1, pp. 23-33
Open Access | Times Cited: 47
Accumulated cholesterol protects tumours from elevated lipid peroxidation in the microenvironment
Xi Zhao, Xinyu Lian, Jianlan Xie, et al.
Redox Biology (2023) Vol. 62, pp. 102678-102678
Open Access | Times Cited: 45
Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance
Hao Zheng, Jinming Liu, Qi Cheng, et al.
Nature Cancer (2024) Vol. 5, Iss. 4, pp. 572-589
Closed Access | Times Cited: 36
Interplay of Ferroptosis and Cuproptosis in Cancer: Dissecting Metal-Driven Mechanisms for Therapeutic Potentials
Jinjiang Wang, Jiaxi Li, Jiao Liu, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 512-512
Open Access | Times Cited: 23
Curcumin Induces Autophagy-mediated Ferroptosis by Targeting the PI3K/AKT/mTOR Signaling Pathway in Gastric Cancer
Xin Zheng, Jun Liu, Wei Hu, et al.
The Turkish Journal of Gastroenterology (2025) Vol. 35, Iss. 8, pp. 625-633
Open Access | Times Cited: 7
Metal Ion Signaling in Biomedicine
Raphaël Rodriguez, Sebastian Müller, Ludovic Colombeau, et al.
Chemical Reviews (2025)
Open Access | Times Cited: 2
Ferroptosis and Autoimmune Diseases
Benjamin Lai, Chien‐Hsiang Wu, Chao‐Yi Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 63
Ferroptosis, necroptosis, and pyroptosis in the occurrence and development of ovarian cancer
Chunmei Zhang, Ning Liu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 56
Novel Iron Oxide Nanoparticles Induce Ferroptosis in a Panel of Cancer Cell Lines
Roberto Fernández-Acosta, Claudia Iriarte‐Mesa, Daniel Alvarez-Almiñaque, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 3970-3970
Open Access | Times Cited: 53
Iron-Sensitive Prodrugs That Trigger Active Ferroptosis in Drug-Tolerant Pancreatic Cancer Cells
Michał Antoszczak, Sebastian Müller, Tatiana Cañeque, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 26, pp. 11536-11545
Closed Access | Times Cited: 49
Targeting Cancer Cell Ferroptosis to Reverse Immune Checkpoint Inhibitor Therapy Resistance
Jingjing Deng, Mei Zhou, Tingting Liao, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 41
The lipoprotein-associated phospholipase A2 inhibitor Darapladib sensitises cancer cells to ferroptosis by remodelling lipid metabolism
Mihee Oh, Seo Young Jang, Ji-Yoon Lee, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 41
Page 1 - Next Page

Scroll to top